Curaleaf Files Update to Offering Circular
Curaleaf (CURLF) has filed an update increasing its offer to acquire all outstanding Aurora Cannabis common shares for implied consideration of US$5.00 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Curaleaf (CURLF) has filed an update increasing its offer to acquire all outstanding Aurora Cannabis common shares for implied consideration of US$5.00 per share. Aurora shareholders would receive 0.4013 Curaleaf subordinate voting shares plus US$1.00 cash per share. The implied value uses Curaleaf's October 2, 2026 closing price of C$14.21 and an exchange rate of C$1.00 to US$0.7015.
The enhanced offer represents an 86% premium to Aurora's US$2.75 30-day volume-weighted average price as of August 10, 2026. The maximum consideration would rise from US$5.00 to US$6.00 per Aurora share, representing a 118% premium to that reference price. Curaleaf filed the update with Canadian securities authorities and a new Form F-80 registration statement with the U.S. Securities and Exchange Commission. The acquisition remains an offer, not a completed transaction.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Hollow bars mark forward-looking points. How the balance works
Positive
- Moderate point. Forward-looking: it has not happened yet and may not happen.The enhanced acquisition offer advances Curaleaf's proposed purchase of all outstanding Aurora common shares.
Negative
- Moderate point. Forward-looking: it has not happened yet and may not happen.0.4013 Curaleaf shares plus US$1.00 cash per Aurora share would dilute holders and require cash consideration.
- Minor point. Forward-looking: it has not happened yet and may not happen.US$5.00 implied consideration carries an 86% premium to Aurora's unaffected reference price and 217% excluding Aurora's cash.
- Minor point. Forward-looking: it has not happened yet and may not happen.Maximum consideration rises from US$5.00 to US$6.00, with premiums of 118% to the unaffected reference price and 295% excluding cash.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Curaleaf has filed a formal update to its Circular incorporating its previously announced increased Offer for Aurora
Curaleaf continues to call on Aurora to engage regarding its Offer and provide shareholders with a comprehensive view of the potential of the combined businesses
Under the terms of the Enhanced Offer, Aurora shareholders would receive total implied consideration of
The Enhanced Offer will also increase the Offer's maximum consideration per Aurora Share from
In addition to making the Enhanced Offer, the Notice of Variation also addresses certain technical comments raised by Aurora to Curaleaf's initial Offering Circular of August 18, 2026. Contrary to Aurora's assertions, Curaleaf does not agree with Aurora's technical comments, including the need to provide pro forma financial statements. Curaleaf has addressed these issues voluntarily, and not in response to any action by any regulator, in order to remove this distraction from the conversation. Rather than focusing on such technicalities, Aurora should engage with Curaleaf, which would enable Curaleaf and Aurora to provide a comprehensive and truly meaningful view of the potential of the combined business.
Curaleaf has filed the Notice of Variation with the applicable Canadian securities regulatory authorities and a new Registration Statement on Form F-80 with the
IMPORTANT INFORMATION
This document does not constitute an offer to buy or the solicitation of an offer to sell any securities. The Offer by Curaleaf to purchase all outstanding common shares of Aurora is made solely by the Offer to Purchase and Circular dated August 18, 2026, as amended by the Notice of Variation and Change and as may be further amended or supplemented.
SECURITY HOLDERS ARE URGED TO READ THE NOTICE OF VARIATION AND CHANGE AS WELL AS THE OFFER TO PURCHASE AND CIRCULAR, THE REGISTRATION STATEMENTS ON FORM F-80, THE TENDER OFFER STATEMENT ON SCHEDULE 14D-1F, AND ALL OTHER RELEVANT DOCUMENTS FILED OR TO BE FILED WITH THE SEC, BECAUSE THEY CONTAIN IMPORTANT INFORMATION. Free copies are available at www.sedarplus.ca, www.sec.gov or by contacting the Information Agent, Carson Proxy Advisors, at 1-800-530-5189 (toll-free), 416-751-2066 (local/text), or info@carsonproxy.com.
NOTICE TO
The enforcement by investors of civil liabilities under the federal securities laws may be affected adversely by the fact that the subject company is located in a foreign country, and that some or all of its officers and directors are residents of a foreign country.
Investors should be aware that the bidder or its affiliates, directly or indirectly, may bid for or make purchases of the issuer's securities subject to the offer or of the issuer's related securities, or of the bidder's securities to be distributed or of the bidder's related securities, during the period of the tender offer, as permitted by applicable Canadian laws or provincial laws or regulations.
Curaleaf has filed with the SEC a Registration Statement on Form F-80 under the
THE OFFER AND THE OFFEROR SHARES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE SEC OR ANY
The Curaleaf Shares to be issued under the Offer have not been registered or otherwise qualified for offer and sale in certain
FORWARD-LOOKING INFORMATION
This document contains "forward-looking information" within the meaning of applicable Canadian securities laws and "forward-looking statements" within the meaning of applicable U.S. securities laws. Such statements relate to, among other things, the expected benefits, timing, and effects of the Offer, and anticipated synergies from a combination of Curaleaf and Aurora. Forward-looking statements can often be identified by words such as "believes," "expects," "anticipates," "may," "will," or similar expressions.
Actual results may differ materially due to risks including: changes in general economic conditions; failure to satisfy conditions to the Offer; failure to realize anticipated synergies; fluctuations in foreign exchange and interest rates; regulatory changes; and other risks described under "Risk Factors" in the Offer to Purchase and Circular. The safe harbor for forward-looking statements does not apply to statements made in connection with a tender offer. Security holders should not place undue reliance on forward-looking information. Curaleaf disclaims any obligation to update forward-looking information except as required by law.
AURORA INFORMATION
Information concerning Aurora herein is based solely on Aurora's publicly available filings and other public sources. Aurora has not reviewed this document. Neither Curaleaf nor its officers or directors assumes responsibility for the accuracy or completeness of such information.
ADDITIONAL INFORMATION
The disposition of Common Shares and the acquisition of Curaleaf shares may have U.S. and Canadian tax consequences; shareholders should consult their own tax advisors and review the tax disclosure contained in the Offer to Purchase and Circular which are available on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov.
About Curaleaf Holdings
Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to enhance lives by cultivating, sharing and celebrating the power of the plant. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf, Select, Grassroots, Find, Dark Heart, and Anthem provide industry-leading service, product selection and accessibility across the medical and adult use markets. Curaleaf International is powered by a strong presence in all stages of the supply chain. Its unique distribution network throughout Europe, Canada and Australasia brings together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Toronto Stock Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit https://ir.curaleaf.com.
Contacts
Media Contact
Kekst CNC
Kekst-Curaleaf@kekstcnc.com
Investor Contact
Curaleaf Holdings, Inc.
IR@curaleaf.com
Shareholder Contact
Carson Proxy Advisors
North American Toll Free Phone: 1-800-530-5189
Local (Collect outside North America): 416-751-2066
Email: info@carsonproxy.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/curaleaf-files-update-to-offering-circular-302899995.html
SOURCE Curaleaf Holdings, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What are the terms of Curaleaf's enhanced offer for Aurora Cannabis?
Aurora shareholders would receive 0.4013 Curaleaf subordinate voting shares plus US$1.00 cash for each Aurora common share. The total implied consideration is US$5.00 per share, based on Curaleaf's October 2, 2026 closing price of C$14.21 and an exchange rate of C$1.00 to US$0.7015. Maximum consideration would increase to US$6.00 per share.